"Executive Summary North America Kirsten Rat Sarcoma (KRAS) Market :
The expected CAGR of the Kirsten rat sarcoma (KRAS) market is around 4.50% in the mentioned forecast period. The market was valued at USD 91.41 million in 2022 and grow to USD 130 million by 2030.
All statistical and numerical data is interpreted with the use of established and advanced tools such as SWOT...
Italiano 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek